COVID-19 updates and information
Our world-class experts. Your child’s care team.
Explore Our Research
Exceptional science. Innovative cures.
Give to help them live.
Join the Game Theorists Nov. 30 for a YouTube livestream from 10 a.m. - 7 p.m. PST to benefit the lifesaving mission of St. Jude.
Read This Patient's Story
Cover for the kids of St. Jude. Cover for the kids in your community. Cover for the kids in your life.
Read Cover for the Kids
We have some of the world's best survival rates for some of the most aggressive cancers.
While out shopping for the perfect gift, visit our corporate partners to learn more about their holiday promotions that give back to St. Jude.
What happens when you give the world’s brightest minds the resources to do something remarkable? Cures.
St. Jude Inspire tells the stories that inspire trust, hope and faith in the mission that drives us: Finding cures. Saving children.
Read our new strategic plan, and learn about our bold vision for the future.
Read This Article
Find inexpensive and thoughtful gifts for your loved ones — all while supporting the lifesaving mission of St. Jude.
Read This Story
We share our research with the world, leading a global effort to understand, treat, and defeat pediatric cancer and other life-threatening diseases.
After Brayden was diagnosed with brain cancer, he received chemotherapy and proton therapy at St. Jude.
Clinical trial data reveals what controls the staying power of T cells, affecting immunotherapy responses.
St. Jude scientists' findings were published in Cell Reports.
St. Jude Children’s Research Hospital scientists have shed light on the way ligands bind to and activate ALK, an important target for cancer drug development.
St. Jude scientists map nutrient-dependent signaling in T cells, offering possible new drug targets for treating infectious diseases, cancer and immune-mediated disorders.
St. Jude Children’s Research Hospital show how epigenetic regulation by the enzyme DNMT3A controls T-cell exhaustion providing a target for improving CAR T–cell immunotherapy.
The fourteen scientists are among the most highly cited investigators in the world during the past decade, reflecting the international reach of
St. Jude research.
St. Jude Children’s Research Hospital scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.
More Science & Medicine